Amamangpan, Gena R.
HRN: 21-52-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/03/2022
07/03/2022
IV
240mg
Once
S/P NSVD With RMLE, Fever
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes